| Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET) M Shokeen, CJ Anderson Accounts of chemical research 42 (7), 832-841, 2009 | 371 | 2009 |
| Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis A Almutairi, R Rossin, M Shokeen, A Hagooly, A Ananth, B Capoccia, ... Proceedings of the National Academy of Sciences 106 (3), 685-690, 2009 | 286 | 2009 |
| Evaluation of multivalent, functional polymeric nanoparticles for imaging applications M Shokeen, ED Pressly, A Hagooly, A Zheleznyak, N Ramos, ... ACS nano 5 (2), 738-747, 2011 | 111 | 2011 |
| Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles M Shokeen, NM Fettig, R Rossin The Quarterly Journal of Nuclear Medicine and Molecular Imaging 52 (3), 267, 2008 | 74 | 2008 |
| Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer N Kotagiri, ML Cooper, M Rettig, C Egbulefu, J Prior, G Cui, P Karmakar, ... Nature communications 9 (1), 275, 2018 | 66 | 2018 |
| Preclinical development of CD38-targeted [89Zr] Zr-DFO-daratumumab for imaging multiple myeloma A Ghai, D Maji, N Cho, C Chanswangphuwana, M Rettig, D Shen, ... Journal of Nuclear Medicine 59 (2), 216-222, 2018 | 58 | 2018 |
| Design of targeted cardiovascular molecular imaging probes CJ Anderson, JWM Bulte, K Chen, X Chen, BA Khaw, M Shokeen, ... Journal of Nuclear Medicine 51 (Supplement 1), 3S-17S, 2010 | 48 | 2010 |
| Very Late Antigen-4 (α4β1 Integrin) Targeted PET Imaging of Multiple Myeloma D Soodgupta, MA Hurchla, M Jiang, A Zheleznyak, KN Weilbaecher, ... PloS one 8 (2), e55841, 2013 | 45 | 2013 |
| Ex vivo and in vivo evaluation of overexpressed VLA-4 in multiple myeloma using LLP2A imaging agents D Soodgupta, H Zhou, W Beaino, L Lu, M Rettig, M Snee, J Skeath, ... Journal of Nuclear Medicine 57 (4), 640-645, 2016 | 43 | 2016 |
| Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors M Jiang, R Ferdani, M Shokeen, CJ Anderson Nuclear medicine and biology 40 (2), 245-251, 2013 | 39 | 2013 |
| Molecular Imaging of Very Late Antigen–4 (α4β1 Integrin) in the Premetastatic Niche M Shokeen, A Zheleznyak, JM Wilson, M Jiang, R Liu, R Ferdani, KS Lam, ... Journal of Nuclear Medicine 53 (5), 779-786, 2012 | 39 | 2012 |
| The development of copper radiopharmaceuticals for imaging and therapy M Shokeen, T J Wadas Medicinal Chemistry 7 (5), 413-429, 2011 | 33 | 2011 |
| Synthesis, Structure, Spectroscopy, and Reactivity of a Neutral Iridathiabenzene1 JR Bleeke, PV Hinkle, M Shokeen, NP Rath Organometallics 23 (17), 4139-4149, 2004 | 31 | 2004 |
| New approaches to molecular imaging of multiple myeloma R Vij, KJ Fowler, M Shokeen Journal of Nuclear Medicine 57 (1), 1-4, 2016 | 30 | 2016 |
| Thiapentadienyl−Rhodium−Phosphine Chemistry1 JR Bleeke, M Shokeen, ES Wise, NP Rath Organometallics 25 (10), 2486-2500, 2006 | 25 | 2006 |
| Osteotropic radiolabeled nanophotosensitizer for imaging and treating multiple myeloma R Tang, A Zheleznyak, M Mixdorf, A Ghai, J Prior, KCL Black, M Shokeen, ... ACS nano 14 (4), 4255-4264, 2020 | 24 | 2020 |
| Assessment of targeted nanoparticle assemblies for atherosclerosis imaging with positron emission tomography and potential for clinical translation Y Liu, HP Luehmann, L Detering, ED Pressly, AJ McGrath, D Sultan, ... ACS applied materials & interfaces 11 (17), 15316-15321, 2019 | 22 | 2019 |
| Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival D Hathi, C Chanswangphuwana, N Cho, F Fontana, D Maji, J Ritchey, ... Scientific reports 12 (1), 30, 2022 | 13 | 2022 |
| Novel agents and future perspectives on theranostics LB Solnes, M Shokeen, N Pandit-Taskar Seminars in radiation oncology 31 (1), 83-92, 2021 | 13 | 2021 |
| Evaluating acetate metabolism for imaging and targeting in multiple myeloma F Fontana, X Ge, X Su, D Hathi, J Xiang, S Cenci, R Civitelli, KI Shoghi, ... Clinical Cancer Research 23 (2), 416-429, 2017 | 13 | 2017 |
